Literature DB >> 646950

Myelomatosis and the hyperviscosity syndrome.

F E Preston, K B Cooke, M E Foster, D A Winfield, D Lee.   

Abstract

Eleven patients are described in whom myelomatosis was complicated by the laboratory and clinical features of the hyperviscosity syndrome (HVS). The myeloma type was IgA in nine and IgG3 in two. In those patients with IgA myeloma the HVS was related to the presence of high molecular weight complexes in the serum. Remission of clinical features was obtained in all patients by plasma exchange. Clinical improvement coincided with reduction of whole blood viscosity and in those patients with IgA myeloma, with a parallel reduction of the high molecular weight complexes. The relationship between the IgA complexes and blood viscosity has been examined by physicochemical analysis of purified IgA monomer and polymers and evidence is presented to show that the IgA polymer has a higher intrinsic viscosity and axial ratio than the larger IgM molecule. The significance of these observations is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646950     DOI: 10.1111/j.1365-2141.1978.tb01077.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation.

Authors:  J K Armstrong; R B Wenby; H J Meiselman; T C Fisher
Journal:  Biophys J       Date:  2004-09-10       Impact factor: 4.033

Review 2.  Antibody-mediated tissue damage. Hyperviscosity and other complications of paraproteinaemia.

Authors:  F E Preston
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

Review 3.  Plasmapheresis in paraproteinemia.

Authors:  H H Euler; N Schmitz; H Löffler
Journal:  Blut       Date:  1985-06

Review 4.  Blood rheology.

Authors:  J Stuart; M W Kenny
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

5.  Relationship between serum viscosity and intravascular IgA polymer concentration in IgA myeloma.

Authors:  K G Chandy; R A Stockley; R C Leonard; R A Crockson; D Burnett; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

6.  Factors affecting IgA related hyperviscosity.

Authors:  U Alkner; U B Hansson; F D Lindström
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

7.  Cerebral infarction in IgG multiple myeloma with hyperviscosity.

Authors:  Man-Seok Park; Byeong-Chae Kim; In-Kyu Kim; Seung-Han Lee; Sung-Min Choi; Myeong-Kyu Kim; Shin-Seok Lee; Ki-Hyun Cho
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.